Brensocatib becomes first licensed treatment for non‑cystic fibrosis bronchiectasis - PharmaTimes MHRA authorises medicine for patients aged 12 and over with repeated flare‑ups

#PharmaTimes #pharma #pharmaceuticals #Brensocatib #Brinsupri #noncysticfibrosisbronchiectasis #MHRA #MedicinesandHealthcareproductsRegulatoryAgency #marketingauthorisation #chroniccondition #dipeptidylpeptidase1 #inflammatoryprocess #lungs #respiratory #JulianBeach
zurl.co/LPYPc

NHS rolls out new initiative to identify pancreatic cancer earlier - PharmaTimes The pilot will see GP practices look at patient records to identify those most at risk

#PharmaTimes #healthcare #diagnostics #NHS #oncology #pancreaticcancer #pancreaticcancerdiagnosis #earlypancreaticcancerdiagnosis #GPpractices #patientrecords #England #ITsystems #cancerdeaths #UK #PeterJohnson
pharmatimes.com/news/nhs-rol...